Imagen Technologies
Category: AI in Healthcare
Physician-led, AI-enabled radiology practice that pairs subspecialist radiologists with proprietary FDA-cleared AI to deliver faster, more accurate diagnostic imaging reads. Imagen Technologies was founded in 2015. The company is led by Alexander (Alex) Dresner. Based in New York, United States. Team size: 101-500. Total funding raised: $234M. Latest round: Venture Round. Key investors include Casdin Capital, GV (Google Ventures), Threshold Ventures, Allen & Company, Brooklyn Bridge Ventures, Teamworthy Ventures, Expanding Capital, Kli Capital, Zach Weinberg.
- Founded
- 2015
- Headquarters
- New York, United States
- Team size
- 101-500
- Total funding
- $234M
Value proposition
Combines subspecialty radiologists, imaging technology and in-house AI to give hospitals, health systems and physician groups faster, more consistent reads, while giving radiologists flexible remote work and a practice built around them.
Products and solutions
Teleradiology and subspecialty interpretation services across X-ray, CT, MRI and ultrasound, cardiology reads, proprietary FDA-cleared AI devices (e.g. Aorta-CAD, a 510(k)-cleared CADe device), national radiology platform with 100% AI-enabled quality tracking
Unique value
A radiology practice and AI developer in one. Clinical operations feed a continuous loop of performance, workflow and physician-experience data back into model development.
Target customer
Hospitals and health systems, physician groups, imaging centers, and radiologists (as recruits)
Industries served
Healthcare, diagnostic imaging, radiology, hospitals and health systems
Technology advantage
Proprietary dataset of more than 200M imaging studies behind several FDA-cleared AI devices. Newly secured rights to up to 150M additional studies for future model training and validation. AI is built in-house and deployed across its own national practice.
How they differentiate
Unlike pure-software imaging AI vendors such as Aidoc, Imagen is a physician-staffed practice that builds and validates its own models on its own clinical workflow. Unlike traditional teleradiology groups, it is a technology-enabled, radiologist-centric model with proprietary AI.
Main competitors
Radiology Partners, vRad (Virtual Radiologic), Aidoc
Key partnerships
Partners with hospitals, health systems, physician groups and imaging centers across about 25-28 states. AI advisory board includes Yann LeCun, Rob Fergus (NYU), Rich Zemel (Columbia) and Serge Belongie (Copenhagen). Radiologist advisory board includes Mayo Clinic, Stanford and HSS faculty.
Major milestones
2015 founded, multiple FDA 510(k) clearances including Aorta-CAD, Feb 2021 $75M Series C, Aug 2026 expanded C-suite as radiologist roster hit 200, Nov 2026 announced $100M+ growth capital and rights to up to 150M additional imaging studies for AI training
Growth metrics
2M+ studies read annually; 200+ radiologists (230+ radiologists and cardiologists per Dealroom), with radiologist headcount roughly doubling year over year; 25-28 states and 200+ sites of care; 90% annual radiologist retention; 17-minute average STAT turnaround; >95% SLA adherence; <1% all-time addendum rate
Market positioning
Technology-enabled national radiology practice, positioned as AI augmenting radiologists rather than replacing them, targeting the radiologist capacity shortage.
Geographic focus
United States (25-28 states)
Patents and IP
Multiple FDA 510(k)-cleared AI devices (e.g. Aorta-CAD); proprietary imaging dataset. Patent count not verified.
About Alexander (Alex) Dresner
Ex-Hospital for Special Surgery; London School of Economics and Political Science. Co-founded Imagen in 2015.
Latest news about Imagen Technologies
More AI in Healthcare companies
Official website: https://imagen.ai